Gardiner Nathaniel S.
SEC CIK 1607643 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ENTA | ENANTA PHARMACEUTICALS INC | SVP, GC | 75.7K | — | $23.2K | 14 | 2021-11-19 | 2024-02-26 |
Most active insiders at ENTA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Luly Jay R. | Pres, CEO, Dir | — | $67.5K |
| 2 | Or Yat Sun | CSO | — | $34.0K |
| 3 | Kieffer Tara Lynn | Chief Product Strategy Off | — | $30.0K |
| 4 | Luu Brendan | Chief Business Off | — | $19.8K |
| 5 | Trout Harry R. III | See Remarks | — | $13.0K |
| 6 | Rottinghaus Scott T. | Chief Medical Off | — | $11.4K |
| 7 | Capps Kathleen S. | See Remarks | — | $7,486 |
| 8 | Kowalsky Matthew Paul | CLO | — | — |
Gardiner Nathaniel S. made no open-market trades at ENTA in the last 12 months.
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-27 | 2024-02-26 | ENTA | ENANTA PHARMACEUTICALS INC | Gardiner Nathaniel S. | CLO | M - OptEx | $8.99 | +5,187 | 75.7K | +7% | +$46.6K |
| 2024-02-14 | 2024-02-12 | ENTA | ENANTA PHARMACEUTICALS INC | Gardiner Nathaniel S. | CLO | F - Tax | $12.41 | -973 | 70.5K | -1% | -$12.1K | |
| 2024-02-14 | 2024-02-12 | ENTA | ENANTA PHARMACEUTICALS INC | Gardiner Nathaniel S. | CLO | A - Grant | $0.00 | +3,320 | 71.5K | +5% | $0 | |
| 2023-12-06 | 2023-12-05 | ENTA | ENANTA PHARMACEUTICALS INC | Gardiner Nathaniel S. | SVP, GC | S - Sale | $9.63 | -2,412 | 68.2K | -3% | -$23.2K | |
| 2023-12-05 | 2023-12-01 | ENTA | ENANTA PHARMACEUTICALS INC | Gardiner Nathaniel S. | SVP, GC | F - Tax | $9.49 | -1,595 | 70.6K | -2% | -$15.1K | |
| D | 2023-04-19 | 2023-04-18 | ENTA | ENANTA PHARMACEUTICALS INC | Gardiner Nathaniel S. | SVP, GC | M - OptEx | $30.00 | +6,667 | 80.0K | +9% | +$200.0K |
| M | 2023-02-15 | 2023-02-13 | ENTA | ENANTA PHARMACEUTICALS INC | Gardiner Nathaniel S. | SVP, GC | A - Grant | $0.00 | +21.0K | 68.3K | +44% | $0 |
| 2023-02-15 | 2023-02-13 | ENTA | ENANTA PHARMACEUTICALS INC | Gardiner Nathaniel S. | SVP, GC | F - Tax | $52.77 | -6,735 | 73.3K | -8% | -$355.4K | |
| 2022-12-05 | 2022-12-01 | ENTA | ENANTA PHARMACEUTICALS INC | Gardiner Nathaniel S. | SVP, GC | F - Tax | $44.33 | -1,055 | 59.1K | -2% | -$46.8K | |
| D | 2022-11-28 | 2022-11-23 | ENTA | ENANTA PHARMACEUTICALS INC | Gardiner Nathaniel S. | SVP, GC | A - Grant | $0.00 | +21.0K | 60.1K | +54% | $0 |
| M | 2022-02-15 | 2022-02-14 | ENTA | ENANTA PHARMACEUTICALS INC | Gardiner Nathaniel S. | SVP, GC | A - Grant | $0.00 | +3,034 | 47.2K | +7% | $0 |
| 2022-02-15 | 2022-02-14 | ENTA | ENANTA PHARMACEUTICALS INC | Gardiner Nathaniel S. | SVP, GC | F - Tax | $62.49 | -957 | 46.2K | -2% | -$59.8K | |
| 2021-12-03 | 2021-12-01 | ENTA | ENANTA PHARMACEUTICALS INC | Gardiner Nathaniel S. | SVP, GC | F - Tax | $87.68 | -557 | 59.2K | -0.9% | -$48.8K | |
| D | 2021-11-23 | 2021-11-19 | ENTA | ENANTA PHARMACEUTICALS INC | Gardiner Nathaniel S. | SVP, GC | A - Grant | $0.00 | +6,800 | 59.8K | +13% | $0 |
Purchase Sale Sale after option exercise All abbreviations